Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/15/25 16:09 | 5/14/25 | OGN | Health | Drug | Pharmaceutical Preparations | Cox Carrie Smith | NJ | D | 1 | P | 101 | 8.07 | 0 | 12 | 12 | D | ||||||||||||||||
5/7/25 12:13 | 5/7/25 | OGN | Health | Drug | Pharmaceutical Preparations | Falcione Aaron | NJ | O | CHRO | 1 | P | 48 | 8.77 | 0 | 6 | 10 | 63 | D | ||||||||||||||
5/7/25 12:12 | 5/6/25 | OGN | Health | Drug | Pharmaceutical Preparations | Weaver Kirke | NJ | O | Gen. Cou | 1 | P | 74 | 9.21 | 0 | 8 | 18 | 52 | D | ||||||||||||||
5/7/25 12:09 | 5/6/25 | OGN | Health | Drug | Pharmaceutical Preparations | Karp Daniel | NJ | O | EVP,Corp | 1 | P | 29 | 8.24 | 0 | 4 | 8 | 47 | D | ||||||||||||||
5/6/25 13:59 | 5/5/25 | OGN | Health | Drug | Pharmaceutical Preparations | Walsh Matthew M | NJ | O | CFO | 1 | P | 101 | 8.82 | 0 | 11 | 9 | 144 | D | ||||||||||||||
5/6/25 13:58 | 5/5/25 | OGN | Health | Drug | Pharmaceutical Preparations | Ali Kevin | NJ | DO | CEO | 1 | P | 299 | 8.81 | 0 | 34 | 14 | 283 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |